Assessing the challenges, opportunities, and investment options in global health R&D Jake Schneider Tuesday, April 24, 2018
Measuring revenue streams and profitability for HIV drugs Darrell M. West and Jake Schneider Monday, April 16, 2018
Five ways to improve private investment in global health R&D Jake Schneider and Darrell M. West Wednesday, March 28, 2018
Are drugs for neglected diseases profitable? Jake Schneider and Jeremy Barofsky Tuesday, December 19, 2017
Promoting private sector involvement in neglected tropical disease research and development Jeremy Barofsky and Jake Schneider Tuesday, December 19, 2017
How much does the private sector invest in global health R&D? Jake Schneider, John Villasenor, and Darrell M. West Tuesday, September 12, 2017
Private Sector Investment in Global Health R&D Darrell M. West, John Villasenor, and Jake Schneider Tuesday, September 12, 2017
How the Trump budget harms global health and weakens international stability Jake Schneider and Darrell M. West Thursday, July 27, 2017
Forum on health governance capacity sees bigger role for private R&D investment Darrell M. West, John Villasenor, and Jake Schneider Friday, April 14, 2017